FBIOX
Fidelity Select Biotechnology Pt
1W: -2.1%
1M: -8.4%
3M: -3.6%
YTD: +13.4%
1Y: +24.8%
3Y: +83.7%
5Y: +33.8%
$28.24
-0.07 (-0.25%)
Weekly Expected Move ±2.8%
$27
$28
$28
$29
$30
ETF-Level Metrics
AUM$6.0B
Holdings155
Top 10 Wt53.2%
Beta0.70
% Profitable13%
Coverage87%
Portfolio Valuation
P/E33.1
P/B9.0
P/S4.8
EV/EBITDA19.3
P/FCF16.0
PEG—
Profitability & Returns
Gross Margin86.5%
Net Margin7.5%
ROE14.6%
ROA2.9%
ROIC16.8%
Div Yield1.20%
Leverage & Liquidity
Debt/Equity2.41
Debt/Assets0.49
Net Debt/EBITDA2.5x
Interest Cov7.2x
Current Ratio0.84
Quick Ratio0.71
Growth (YoY)
Revenue+30.0%
Net Income+22.2%
EPS+30.6%
FCF+14.0%
EBITDA+30.6%
Rev CAGR 3Y+46.3%
Quality Scores
Piotroski F4.6
Altman Z26.92
IS Quality58.5
IS Overall51.4
IS Value37.0
Median P/E-6.3
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 153 | 86.2% | -16.5 |
| Financial Services | 2 | 9.3% | 5.2 |
| Other | 36 | 7.0% | — |
Smart Money Overlap
1 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | 0.35% | 3 | Bullish | 1 | 0 | +99.5% |
Showing 50 of 191 holdings
· Page 1 of 4
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | ABBVIE INC | 4AB.DE | 13.22% | $707.7M | 3,049,432 | 74.0 | $408.1B | Healthcare |
| 2 | KRYSTAL BIOTECH INC | KRTA.F | 9.30% | $497.9M | 1,806,522 | 10.4 | $2.2B | Financial Services |
| 3 | GILEAD SCIENCES INC | GILD.SW | 8.77% | $469.2M | 3,149,952 | -55.7 | $143.2B | Healthcare |
| 4 | AMGEN INC | 4332.HK | 8.34% | $446.2M | 1,149,551 | — | $998.5B | Healthcare |
| 5 | ALNYLAM PHARMACEUTICALS INC | 0HD2.L | 3.09% | $165.4M | 496,683 | 36.0 | $29.7B | Healthcare |
| 6 | Fidelity Revere Street Trust Private | — | 2.55% | $136.2M | 136,216,589 | — | — | — |
| 7 | PRAXIS PRECISION MEDICINES INC. | PRAX | 2.46% | $131.5M | 390,500 | -22.8 | $8.2B | Healthcare |
| 8 | ASCENDIS PHARMA A/S Private | — | 2.44% | $130.3M | 558,201 | — | — | — |
| 9 | INSMED INC | 0JAV.L | 2.26% | $121.1M | 811,101 | -27.0 | $23.7B | Healthcare |
| 10 | UCB SA | UCB.BR | 2.17% | $98.5M | 390,274 | 17.7 | $38.9B | Healthcare |
| 11 | ARGENX SE | ARGNF | 2.14% | $114.5M | 149,344 | 33.3 | $58.2B | Healthcare |
| 12 | REGENERON PHARMACEUTICALS INC | 0R2M.L | 1.48% | $79.2M | 101,316 | 17.6 | $79.6B | Healthcare |
| 13 | MODERNA INC | 0QF.F | 1.43% | $76.7M | 1,432,529 | -23.8 | $66.4B | Healthcare |
| 14 | SCHOLAR ROCK HOLDING CORP | SRRK | 1.37% | $73.1M | 1,650,449 | -14.1 | $5.6B | Healthcare |
| 15 | NATERA INC | NTRA | 1.29% | $69.0M | 331,532 | -301.7 | $58.8B | Healthcare |
| 16 | COGENT BIOSCIENCES INC | COGT | 1.23% | $65.7M | 1,691,394 | -13.4 | $5.3B | Healthcare |
| 17 | CENTESSA PHARMACEUTICALS PLC | CNTA | 1.10% | $58.8M | 2,187,494 | -22.8 | $6.3B | Healthcare |
| 18 | BIOGEN INC | BIIB.SW | 1.07% | $57.4M | 299,435 | 30.0 | $20.8B | Healthcare |
| 19 | ROIVANT SCIENCES LTD | ROIVW | 1.07% | $57.1M | 1,972,719 | -4.3 | $2.0B | Healthcare |
| 20 | VERTEX PHARMACEUTICALS INC | VX1.DE | 1.05% | $56.1M | 112,900 | 29.1 | $113.3B | Healthcare |
| 21 | BRIDGEBIO PHARMA INC | BBIO | 0.88% | $47.0M | 707,304 | -18.8 | $13.2B | Healthcare |
| 22 | PROTAGONIST THERAPEUTICS INC | PTGX | 0.87% | $46.7M | 506,713 | 115.0 | $9.0B | Healthcare |
| 23 | IMMUNOME INC | IMNM | 0.87% | $46.6M | 2,131,664 | -8.2 | $2.0B | Healthcare |
| 24 | TERNS PHARMACEUTICALS INC | TERN | 0.85% | $45.5M | 1,079,186 | -51.4 | $4.8B | Healthcare |
| 25 | REVOLUTION MEDICINES INC | RVMD | 0.84% | $44.8M | 438,772 | -23.3 | $43.9B | Healthcare |
| 26 | KYMERA THERAPEUTICS INC | KYMR | 0.79% | $42.2M | 462,441 | -33.0 | $8.8B | Healthcare |
| 27 | IONIS PHARMACEUTICALS INC | 0JDI.L | 0.72% | $38.7M | 476,377 | -12.6 | $7.1B | Healthcare |
| 28 | ARRIVENT BIOPHARMA INC | AVBP | 0.72% | $38.6M | 1,680,003 | -7.7 | $1.3B | Healthcare |
| 29 | CRINETICS PHARMACEUTICALS INC | CRNX | 0.71% | $38.1M | 926,671 | -16.8 | $9.0B | Healthcare |
| 30 | ABIVAX SA | ABVX | 0.68% | $36.6M | 301,600 | -17.7 | $6.8B | Healthcare |
| 31 | STRUCTURE THERAPEUTICS INC | GPCR | 0.66% | $35.5M | 564,438 | -9.1 | $1.6B | Healthcare |
| 32 | DISC MEDICINE INC | IRON | 0.66% | $35.5M | 532,174 | -9.8 | $2.5B | Healthcare |
| 33 | GALDERMA GROUP AG | GALD.SW | 0.65% | $26.8M | 184,660 | 47.4 | $37.4B | Healthcare |
| 34 | ZEALAND PHARMA A/S | ZEAL.CO | 0.63% | $214.3M | 589,130 | 6.8 | $18.2B | Healthcare |
| 35 | CYTOKINETICS INC | CYTK | 0.59% | $31.3M | 503,175 | -9.1 | $8.2B | Healthcare |
| 36 | CANDEL THERAPEUTICS INC | CADL | 0.58% | $31.0M | 5,911,951 | -7.2 | $746M | Healthcare |
| 37 | VIRIDIAN THERAPEUTICS INC | 0K1R.L | 0.55% | $29.4M | 1,001,204 | -5.5 | $1.7B | Healthcare |
| 38 | VAXCYTE INC | PCVX | 0.54% | $29.0M | 470,455 | -7.4 | $8.2B | Healthcare |
| 39 | STOKE THERAPEUTICS INC | STOK | 0.54% | $28.9M | 792,594 | -7.6 | $1.7B | Healthcare |
| 40 | NUVALENT INC | NUVL | 0.52% | $27.9M | 273,399 | -20.5 | $9.1B | Healthcare |
| 41 | APOGEE THERAPEUTICS INC | APGE | 0.51% | $27.5M | 392,757 | -31.1 | $8.4B | Healthcare |
| 42 | TREVI THERAPEUTICS INC | TRVI | 0.51% | $27.3M | 2,288,485 | -41.2 | $2.0B | Healthcare |
| 43 | ANNEXON INC | ANNX | 0.50% | $26.5M | 4,733,596 | -3.6 | $687M | Healthcare |
| 44 | ARROWHEAD PHARMACEUTICALS INC | 0HI3.L | 0.48% | $25.9M | 409,378 | -28.7 | $9.0B | Healthcare |
| 45 | DIANTHUS THERAPEUTICS INC | DNTH | 0.45% | $23.9M | 432,218 | -678.5 | $4.9B | Healthcare |
| 46 | VOR BIOPHARMA INC | VOR | 0.44% | $23.7M | 1,536,125 | -0.1 | $1.0B | Healthcare |
| 47 | EDGEWISE THERAPEUTICS INC | EWTX | 0.44% | $23.6M | 776,925 | -22.4 | $4.5B | Healthcare |
| 48 | UNITED THERAPEUTICS CORP DEL | UTHR | 0.42% | $22.5M | 44,593 | 17.9 | $23.0B | Healthcare |
| 49 | INTELLIA THERAPEUTICS INC | 0JBU.L | 0.41% | $22.2M | 1,607,833 | -3.6 | $1.4B | Healthcare |
| 50 | TRAVERE THERAPEUTICS INC | TVTX | 0.40% | $21.5M | 720,343 | -126.5 | $5.3B | Healthcare |